title: Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.
authors.affiliation: Department of Hematology, Tokyo Medical University, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Katagiri
authors.affiliation: Department of Hematology, Tokyo Medical University, Tokyo, Japan.
authors.forename: D
authors.initials: D
authors.lastname: Akahane
authors.affiliation: Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Amano
authors.affiliation: Department of Hematology, Tokyo Medical University, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ohyashiki
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069286:Bortezomib / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications*; D014842:von Willebrand Diseases / Q000150:complications*
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000069286:Bortezomib; D003907:Dexamethasone